MM 55266

N/A

Report date: 2025/03/18 14:23:16
NME

Base Information

Drug NameMM 55266
Drug Alias NameMM 55266MM-55266
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Glycopeptide antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A